animal studies suggest it may support healing of gastric ulcers and damaged intestinal lining Preclinical models suggest it may help modulate inflammation, though this has not been established in controlled human trials Known risks and side effects: Because it is sold as an unregulated research chemical rather than a manufactured pharmaceutical, product purity and dosing accuracy cannot be verified, and the FDA has flagged potential impurities and manufacturing-quality concerns FDA's Category 2 determination specifically cited potential immune reactions and hypersensitivity as a safety concern User-reported (non-clinical-trial) effects include injection-site irritation, redness, or swelling, along with occasional headache, nausea, or lightheadedness, based on anecdotal reporting rather than controlled studies No long-term human safety data exists
Hair thinning was reported as a side effect in some clinical trials of GLP-1 drugs, says Anthony Rossi, MD, a dermatologist and skin cancer surgeon at Memorial Sloan Kettering Cancer Center in New York City, who was not involved in the study
Taha M, et al
However, if cloudiness persists after several minutes, the product may be compromised
Ipamorelin may also be offered as a pill
In non-clinical research literature, the GHK-Cu peptide is discussed as a signaling molecule that works at the cellular level, including effects on human genes tied to tissue repair, collagen synthesis, collagen and elastin remodeling, glycosaminoglycan expression, and overall skin quality within controlled laboratory systems
